TAG:
blood brothers
Low Lab Test Prices and Uninsured Patients
By R. Lewis Dark | From the Volume XVIII No. 3 – February 28, 2011 Issue
LOW PRICES FOR CLINICAL LABORATORY TESTS ARE CAUSING PROBLEMS for labs in California and Ohio. In this issue of THE DARK REPORT, you will learn about both situations. The California situation has gotten lots of play, but the Ohio situation is breaking news. In California, both the California Attorne…
Expect Changes in How Calif. Labs Set Test Prices
By Robert Michel | From the Volume XVIII No. 2 – February 7, 2011 Issue
CEO SUMMARY: What a difference two years makes. Back in April 2009, when then-Attorney General Jerry Brown joined the whistleblower lawsuit alleging that seven or more California lab companies had violated state law on pricing provider services, the popular wisdom among lab execu…
$241 Million May Settle Quest Medi-Cal Claims
By Robert Michel | From the Volume XVIII No. 2 – February 7, 2011 Issue
CEO SUMMARY: There’s movement in the negotiations between California state officials and Quest Diagnostics Incorporated over allegations that discounted lab test prices violated state law. In January, Quest disclosed that it had an “understanding” with California regulators…
Reading the Tea Leaves from 2010’s Events
By R. Lewis Dark | From the Volume XVII No. 17 – December 6, 2010 Issue
EACH YEAR WHEN WE PRESENT OUR “Top Ten Lab Stories” for the year, I am always surprised at which forces for change emerged during the prior 12 months. In presenting THE DARK REPORT’S “Top Ten Lab Stories for 2010,” our editor has pointed out that four of these ten stories involved the feder…
Aetna Sues LabCorp Over Lab Marketing Practices
By Robert Michel | From the Volume XVII No. 16 – November 15, 2010 Issue
CEO SUMMARY: Aetna, Inc., sued Laboratory Corporation of America in federal court, seeking injuctive relief for actions taken once LabCorp became an out-of-network laboratory provider for Aetna in July 2007. LabCorp is also accused of a “malicious scheme to continue to receive …
Q3 Earnings Are Mixed Bag For the Two Blood Brothers
By Robert Michel | From the Volume XVII No. 15 – October 25, 2010 Issue
IF THERE IS A NOTABLE EVENT in the laboratory testing marketplace during 2010, it is that one of the nation’s billion-dollar lab testing behemoths has reported three consecutive quarters of declines in the number of test requisitions it handled, when compared to the same quarters during 2009. In t…
More Hospitals Consider PAML’s Lab JV Model
By Robert Michel | From the Volume XVII No. 13 – September 13, 2010 Issue
CEO SUMMARY: One joint venture at a time, PAML is convincing hospital and health system CEOs about the benefits of building a thriving laboratory outreach business. For their part, facing budget cutbacks and a decline in Medicare reimbursement, more hospital administrato…
Specimen Volume Declines Reported By Quest Diagnostics and LabCorp
By Robert Michel | From the Volume XVII No. 11 – August 2, 2010 Issue
IN REPORTING SECOND QUARTER EARNINGS, there was enough difference in the numbers announced by Quest Diagnostics Incorporated and Laboratory Corporation of America to catch the attention of financial analysts. Revenue at LabCorp was up for the quarter while revenue a…
Westcliff Labs Announces BK and Sale to LabCorp
By Robert Michel | From the Volume XVII No. 8 – June 1, 2010 Issue
CEO SUMMARY: Subject to court approval, Laboratory Corporation of America is poised to acquire the assets of California-based Westcliff Medical Laboratories, Inc., which just filed a Chapter 11 bankruptcy action in federal court on May 19. In a separate transaction, LabCorp has a…
Assessing the Year-End Financials For Nation’s Biggest Lab Companies
By Robert Michel | From the Volume XVII No. 4 – March 8, 2010 Issue
IN RECENT WEEKS, the last of the nation’s largest public laboratory companies released year-end 2009 financial reports. Each lab firm’s financial report provides useful insights about active trends in the lab testing marketplace, particularly in lab testing referred by office-based physicians. …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized